drugset / Trial / NCT01302145

Drug to Drug Interaction Study With ASP1941 and Metformin

NCT01302145

Phase 1 Completed 36 enrolled Astellas Pharma Inc
RandomizedParallel-groupDouble-blindBasic science

Summary

A study to investigate the effect on safety, pharmacokinetics and pharmacodynamics when ASP1941 is administered as add-on therapy to metformin.

Timeline

Start
2009-02-25
Primary completion
2009-12-09
Completion
2009-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg Oral
Subject Metformin Small molecule 1000 mg Oral
Subject Metformin Small molecule 1500 mg Oral
Subject ipragliflozin Small molecule 300 mg Oral